ANTIBODY RESPONSES TO 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE AFTER PRIMARY AND REVACCINATION

Despite increasing risk for pneumococcal disease with advancing age, many countries recommend only a single dose of pneumococcal polysaccharide vaccine (PPSV23) for older adults. Concerns about the possibility of declining response to revaccination with age have hindered the adoption of a revaccinat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Innov Aging
Hlavní autoři: Kawakami, K., Kishino, H., Kanazu, S., Toshimuzu, N., Yokokawa, R., Takahashi, K., Kohn, M., Musey, L.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6242382/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igx004.787
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky